{
    "clinical_study": {
        "@rank": "137880", 
        "arm_group": [
            {
                "arm_group_label": "1:Semaglutide tablets : 2.5 mg", 
                "arm_group_type": "Experimental", 
                "description": "2.5 mg for 26 weeks. All arms include 26 weeks of treatment and a 5 week follow-up period. The trial medication will be add-on to metformin therapy or as monotherapy in the case where the subject is treated with diet and exercise alone."
            }, 
            {
                "arm_group_label": "2:Semaglutide tablets: 2.5 mg/5 mg", 
                "arm_group_type": "Experimental", 
                "description": "2.5 mg for 4 weeks, then 5.0 mg for 22 weeks. All arms include 26 weeks of treatment and a 5 week follow-up period. The trial medication will be add-on to metformin therapy or as monotherapy in the case where the subject is treated with diet and exercise alone."
            }, 
            {
                "arm_group_label": "3:Semaglutide tablets: 5.0 mg/10 mg", 
                "arm_group_type": "Experimental", 
                "description": "5.0 mg for 4 weeks, then 10 mg for 22 weeks. All arms include 26 weeks of treatment and a 5 week follow-up period. The trial medication will be add-on to metformin therapy or as monotherapy in the case where the subject is treated with diet and exercise alone."
            }, 
            {
                "arm_group_label": "4:Semaglutide tablets:5.0 mg/10 mg/20 mg", 
                "arm_group_type": "Experimental", 
                "description": "5.0 mg for 4 weeks, then 10 mg for 4 weeks, then 20 mg for 18 weeks. All arms include 26 weeks of treatment and a 5 week follow-up period. The trial medication will be add-on to metformin therapy or as monotherapy in the case where the subject is treated with diet and exercise alone."
            }, 
            {
                "arm_group_label": "5:Semaglutide tablets:5.0 mg/10 mg/20 mg/40 mg", 
                "arm_group_type": "Experimental", 
                "description": "5.0 mg for 4 weeks, then 10 mg for 4 weeks, then 20 mg for 4 weeks, then 40 mg for 14 weeks.\nAll arms include 26 weeks of treatment and a 5 week follow-up period. The trial medication will be add-on to metformin therapy or as monotherapy in the case where the subject is treated with diet and exercise alone."
            }, 
            {
                "arm_group_label": "6:Semaglutide tablets:5.0 mg/10 mg/20 mg/40 mg", 
                "arm_group_type": "Experimental", 
                "description": "5.0 mg for 8 weeks, then 10 mg for 8 weeks, then 20 mg for 8 weeks, then 40 mg for 2 weeks All arms include 26 weeks of treatment and a 5 week follow-up period. The trial medication will be add-on to metformin therapy or as monotherapy in the case where the subject is treated with diet and exercise alone."
            }, 
            {
                "arm_group_label": "7:Semaglutide tablets: 5.0 mg/10 mg/20 mg/40 mg", 
                "arm_group_type": "Experimental", 
                "description": "5.0 mg for 2 weeks, then 10 mg for 2 weeks, then 20 mg for 2 weeks, then 40 mg for 20 weeks.\nAll arms include 26 weeks of treatment and a 5 week follow-up period. The trial medication will be add-on to metformin therapy or as monotherapy in the case where the subject is treated with diet and exercise alone."
            }, 
            {
                "arm_group_label": "8:Placebo tablets", 
                "arm_group_type": "Placebo Comparator", 
                "description": "All arms include 26 weeks of treatment and a 5 week follow-up period. The trial medication will be add-on to metformin therapy or as monotherapy in the case where the subject is treated with diet and exercise alone."
            }, 
            {
                "arm_group_label": "9:Semaglutide injections :0.25 mg/0.50 mg/1.0 mg", 
                "arm_group_type": "Active Comparator", 
                "description": "0.25 mg for 4 weeks, then 0.50 mg for 4 weeks, then 1.0 mg for 18 weeks. All arms include 26 weeks of treatment and a 5 week follow-up period. The trial medication will be add-on to metformin therapy or as monotherapy in the case where the subject is treated with diet and exercise alone."
            }
        ], 
        "brief_summary": {
            "textblock": "This trial is conducted globally. The aim of the trial is to examine the dose range,\n      escalation and efficacy of oral semaglutide in subjects with type 2 diabetes."
        }, 
        "brief_title": "Multiple Dose Trial Examining Dose Range, Escalation and Efficacy of Oral Semaglutide in Subjects With Type 2 Diabetes", 
        "completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Diabetes", 
            "Diabetes Mellitus, Type 2"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Diabetes Mellitus", 
                "Diabetes Mellitus, Type 2"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  BMI above or equal to 25 and below or equal to 40 kg/m^2\n\n          -  Subjects diagnosed with T2D (Type 2 diabetes) treated with diet and exercise and/or\n             who have been on a stable dose of metformin for at least 30 days prior to screening\n\n          -  HbA1c 7.0-9.5% (53-80 mmol/mol) (both inclusive)\n\n        Exclusion Criteria:\n\n          -  Subjects on selected oral medication with a narrow therapeutic window, such as\n             warfarin, digoxin, tricyclic antidepressants, lithium, aminophylline, theophylline\n             and anticonvulsants\n\n          -  History of chronic pancreatitis or idiopathic acute pancreatitis\n\n          -  Chronic malabsorption, regardless of aetiology\n\n          -  History of Crohn's disease, ulcerative colitis, or other inflammatory bowel disease\n\n          -  Treatment with glucose lowering agent(s) other than metformin as stated in the\n             inclusion criteria in a period of 90 days before the screening visit"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "603", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 13, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01923181", 
            "org_study_id": "NN9924-3790", 
            "secondary_id": [
                "2012-004994-16", 
                "U1111-1136-4716"
            ]
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "1:Semaglutide tablets : 2.5 mg", 
                    "2:Semaglutide tablets: 2.5 mg/5 mg", 
                    "3:Semaglutide tablets: 5.0 mg/10 mg", 
                    "4:Semaglutide tablets:5.0 mg/10 mg/20 mg", 
                    "5:Semaglutide tablets:5.0 mg/10 mg/20 mg/40 mg", 
                    "6:Semaglutide tablets:5.0 mg/10 mg/20 mg/40 mg", 
                    "7:Semaglutide tablets: 5.0 mg/10 mg/20 mg/40 mg"
                ], 
                "description": "Once-daily oral administration as tablets.", 
                "intervention_name": "semaglutide", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "9:Semaglutide injections :0.25 mg/0.50 mg/1.0 mg", 
                "description": "Once-weekly,injected s.c./subcutaneously (under the skin) using a pen", 
                "intervention_name": "semaglutide", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "8:Placebo tablets", 
                "description": "Once-daily oral administration as tablets.", 
                "intervention_name": "oral placebo", 
                "intervention_type": "Drug"
            }
        ], 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "April 24, 2014", 
        "link": {
            "description": "Clinical Trials at Novo Nordisk", 
            "url": "http://novonordisk-trials.com"
        }, 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Tucson", 
                        "country": "United States", 
                        "state": "Arizona", 
                        "zip": "85712"
                    }, 
                    "name": "Novo Nordisk Clinical Trial Call Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chula Vista", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "91911"
                    }, 
                    "name": "Novo Nordisk Clinical Trial Call Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Long Beach", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "90806"
                    }, 
                    "name": "Novo Nordisk Clinical Trial Call Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Poway", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "92064"
                    }, 
                    "name": "Novo Nordisk Clinical Trial Call Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Santa Ana", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "92705"
                    }, 
                    "name": "Novo Nordisk Clinical Trial Call Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Spring Valley", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "91978"
                    }, 
                    "name": "Novo Nordisk Clinical Trial Call Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Walnut Creek", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "94598"
                    }, 
                    "name": "Novo Nordisk Clinical Trial Call Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Colorado Springs", 
                        "country": "United States", 
                        "state": "Colorado", 
                        "zip": "80904"
                    }, 
                    "name": "Novo Nordisk Clinical Trial Call Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Denver", 
                        "country": "United States", 
                        "state": "Colorado", 
                        "zip": "80220"
                    }, 
                    "name": "Novo Nordisk Clinical Trial Call Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Jacksonville", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "32207"
                    }, 
                    "name": "Novo Nordisk Clinical Trial Call Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Miami", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33014"
                    }, 
                    "name": "Novo Nordisk Clinical Trial Call Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Plantation", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33324"
                    }, 
                    "name": "Novo Nordisk Clinical Trial Call Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "South Miami", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33143"
                    }, 
                    "name": "Novo Nordisk Clinical Trial Call Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Athens", 
                        "country": "United States", 
                        "state": "Georgia", 
                        "zip": "30606"
                    }, 
                    "name": "Novo Nordisk Clinical Trial Call Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Conyers", 
                        "country": "United States", 
                        "state": "Georgia", 
                        "zip": "30094-5965"
                    }, 
                    "name": "Novo Nordisk Clinical Trial Call Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Addison", 
                        "country": "United States", 
                        "state": "Illinois", 
                        "zip": "60101"
                    }, 
                    "name": "Novo Nordisk Clinical Trial Call Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chicago", 
                        "country": "United States", 
                        "state": "Illinois", 
                        "zip": "60634"
                    }, 
                    "name": "Novo Nordisk Clinical Trial Call Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Wichita", 
                        "country": "United States", 
                        "state": "Kansas", 
                        "zip": "67203"
                    }, 
                    "name": "Novo Nordisk Clinical Trial Call Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Rockville", 
                        "country": "United States", 
                        "state": "Maryland", 
                        "zip": "20852"
                    }, 
                    "name": "Novo Nordisk Clinical Trial Call Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Las Vegas", 
                        "country": "United States", 
                        "state": "Nevada", 
                        "zip": "89103"
                    }, 
                    "name": "Novo Nordisk Clinical Trial Call Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Las Vegas", 
                        "country": "United States", 
                        "state": "Nevada", 
                        "zip": "89109"
                    }, 
                    "name": "Novo Nordisk Clinical Trial Call Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10001"
                    }, 
                    "name": "Novo Nordisk Clinical Trial Call Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Rochester", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "14609"
                    }, 
                    "name": "Novo Nordisk Clinical Trial Call Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Asheville", 
                        "country": "United States", 
                        "state": "North Carolina", 
                        "zip": "28803"
                    }, 
                    "name": "Novo Nordisk Clinical Trial Call Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Raleigh", 
                        "country": "United States", 
                        "state": "North Carolina", 
                        "zip": "27609"
                    }, 
                    "name": "Novo Nordisk Clinical Trial Call Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Salisbury", 
                        "country": "United States", 
                        "state": "North Carolina", 
                        "zip": "28144"
                    }, 
                    "name": "Novo Nordisk Clinical Trial Call Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Fargo", 
                        "country": "United States", 
                        "state": "North Dakota", 
                        "zip": "58103-6413"
                    }, 
                    "name": "Novo Nordisk Clinical Trial Call Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Norman", 
                        "country": "United States", 
                        "state": "Oklahoma", 
                        "zip": "73069"
                    }, 
                    "name": "Novo Nordisk Clinical Trial Call Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Jersey shore", 
                        "country": "United States", 
                        "state": "Pennsylvania", 
                        "zip": "17740"
                    }, 
                    "name": "Novo Nordisk Clinical Trial Call Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Philadelphia", 
                        "country": "United States", 
                        "state": "Pennsylvania", 
                        "zip": "19140"
                    }, 
                    "name": "Novo Nordisk Clinical Trial Call Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Philadelphia", 
                        "country": "United States", 
                        "state": "Pennsylvania", 
                        "zip": "19147"
                    }, 
                    "name": "Novo Nordisk Clinical Trial Call Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Moncks Corner", 
                        "country": "United States", 
                        "state": "South Carolina", 
                        "zip": "29461"
                    }, 
                    "name": "Novo Nordisk Clinical Trial Call Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Humboldt", 
                        "country": "United States", 
                        "state": "Tennessee", 
                        "zip": "38343"
                    }, 
                    "name": "Novo Nordisk Clinical Trial Call Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Spring Hill", 
                        "country": "United States", 
                        "state": "Tennessee", 
                        "zip": "37174"
                    }, 
                    "name": "Novo Nordisk Clinical Trial Call Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Dallas", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "75230"
                    }, 
                    "name": "Novo Nordisk Clinical Trial Call Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Antonio", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "78209"
                    }, 
                    "name": "Novo Nordisk Clinical Trial Call Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sugarland", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "77478"
                    }, 
                    "name": "Novo Nordisk Clinical Trial Call Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Norfolk", 
                        "country": "United States", 
                        "state": "Virginia", 
                        "zip": "23502"
                    }, 
                    "name": "Novo Nordisk Clinical Trial Call Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Wenatchee", 
                        "country": "United States", 
                        "state": "Washington", 
                        "zip": "98801-2028"
                    }, 
                    "name": "Novo Nordisk Clinical Trial Call Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Graz", 
                        "country": "Austria", 
                        "zip": "8036"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sofia", 
                        "country": "Bulgaria", 
                        "zip": "1431"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bathurst", 
                        "country": "Canada", 
                        "state": "New Brunswick", 
                        "zip": "E2A 4Z9"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "\u00c5rhus C", 
                        "country": "Denmark", 
                        "zip": "8000"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hamburg", 
                        "country": "Germany", 
                        "zip": "22607"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Beer Sheva", 
                        "country": "Israel", 
                        "zip": "84101"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Roma", 
                        "country": "Italy", 
                        "zip": "00161"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kota Bharu", 
                        "country": "Malaysia", 
                        "zip": "15000"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Belgrade", 
                        "country": "Serbia", 
                        "zip": "11000"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Port Elizabeth", 
                        "country": "South Africa", 
                        "state": "Eastern Cape", 
                        "zip": "6045"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sevilla", 
                        "country": "Spain", 
                        "zip": "41003"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Karlstad", 
                        "country": "Sweden", 
                        "zip": "651 85"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "London", 
                        "country": "United Kingdom", 
                        "zip": "W6 7HY"
                    }
                }
            }
        ], 
        "location_countries": {
            "country": [
                "United States", 
                "Austria", 
                "Bulgaria", 
                "Canada", 
                "Denmark", 
                "Germany", 
                "Israel", 
                "Italy", 
                "Malaysia", 
                "Serbia", 
                "South Africa", 
                "Spain", 
                "Sweden", 
                "United Kingdom"
            ]
        }, 
        "number_of_arms": "9", 
        "official_title": "Multiple Dose Trial Examining Dose Range, Escalation and Efficacy of Oral Semaglutide in Subjects With Type 2 Diabetes", 
        "overall_official": {
            "affiliation": "Novo Nordisk A/S", 
            "last_name": "Global Clinical Registry (GCR, 1452)", 
            "role": "Study Director"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": [
                "Austria: Agency for Health and Food Safety", 
                "Bulgaria: Ministry of Health", 
                "Canada: Health Canada", 
                "Denmark: Danish Medicines Agency", 
                "Germany: Federal Institute for Drugs and Medical Devices", 
                "Israel: Ministry of Health", 
                "Italy: Ministry of Health", 
                "Malaysia: Ministry of Health", 
                "Serbia: Agency for Drugs and Medicinal Devices", 
                "South Africa: Medicines Control Council", 
                "Spain: Spanish Agency of Medicines", 
                "Sweden: Medical Products Agency", 
                "United Kingdom: Medicines and Healthcare Products Regulatory Agency", 
                "United States: Food and Drug Administration"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Change in HbA1c (Glycosylated haemoglobin))", 
            "safety_issue": "No", 
            "time_frame": "Week 0, Week 26"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01923181"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Subjects who achieve (yes/no) HbA1c below 7 percent (53 mmol/mol)", 
                "safety_issue": "No", 
                "time_frame": "After 26 weeks of treatment"
            }, 
            {
                "measure": "Change in body weight", 
                "safety_issue": "No", 
                "time_frame": "Week 0, Week 26"
            }, 
            {
                "measure": "Change in waist circumference", 
                "safety_issue": "No", 
                "time_frame": "week 0, week 26"
            }, 
            {
                "measure": "Change in body mass index (BMI)", 
                "safety_issue": "No", 
                "time_frame": "week 0, week 26"
            }, 
            {
                "measure": "Number of treatment emergent adverse events (TEAEs) recorded", 
                "safety_issue": "No", 
                "time_frame": "Weeks 0-31"
            }, 
            {
                "measure": "Number of confirmed hypoglycaemic episodes recorded", 
                "safety_issue": "No", 
                "time_frame": "Weeks 0-31"
            }
        ], 
        "source": "Novo Nordisk A/S", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Novo Nordisk A/S", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "December 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}